Literature DB >> 16900522

Cystatin C in cerebrospinal fluid and multiple sclerosis.

Sara F Hansson1, Anja Hviid Simonsen, Henrik Zetterberg, Oluf Andersen, Sara Haghighi, Inger Fagerberg, Ulf Andréasson, Ann Westman-Brinkmalm, Anders Wallin, Ulla Rüetschi, Kaj Blennow.   

Abstract

OBJECTIVE: A recent study using surface-enhanced laser desorption/ionization time-of-flight analysis of cerebrospinal fluid identified a 12.5 kDa truncated isoform of cystatin C (CysC) as a specific biomarker for multiple sclerosis (MS).
METHODS: Surface-enhanced laser desorption/ionization time-of-flight analysis of cerebrospinal fluid samples from 43 MS patients and 46 healthy control subjects.
RESULTS: Full-length CysC (13.4 kDa) concentration was similar in MS and control samples. The 12.5 kDa CysC protein was produced from full-length CysC by N-terminal cleavage during storage at -20 degrees C.
INTERPRETATION: The 12.5 kDa CysC isoform is a storage-related artifact and is not useful as a diagnostic marker for MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16900522     DOI: 10.1002/ana.20945

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.

Authors:  Henrik Ryberg; Jiyan An; Samuel Darko; Jonathan Llyle Lustgarten; Matt Jaffa; Vanathi Gopalakrishnan; David Lacomis; Merit Cudkowicz; Robert Bowser
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

2.  Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.

Authors:  Maria Bjerke; Erik Portelius; Lennart Minthon; Anders Wallin; Henrik Anckarsäter; Rolf Anckarsäter; Niels Andreasen; Henrik Zetterberg; Ulf Andreasson; Kaj Blennow
Journal:  Int J Alzheimers Dis       Date:  2010-07-15

Review 3.  Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.

Authors:  Violaine K Harris; Saud A Sadiq
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 4.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

5.  Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models.

Authors:  Mohit Raja Jain; Wei-Wen Ge; Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2008-05-01       Impact factor: 3.494

6.  Proteomic strategies in multiple sclerosis and its animal models.

Authors:  Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2007-10-16       Impact factor: 3.494

7.  Serum profiling by MALDI-TOF mass spectrometry as a diagnostic tool for domoic acid toxicosis in California sea lions.

Authors:  Benjamin A Neely; Jennifer L Soper; Denise J Greig; Kevin P Carlin; Elizabeth G Favre; Frances Md Gulland; Jonas S Almeida; Michael G Janech
Journal:  Proteome Sci       Date:  2012-03-19       Impact factor: 2.480

8.  Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis.

Authors:  Dana Haves-Zburof; Tamar Paperna; Alumit Gour-Lavie; Ilana Mandel; Lea Glass-Marmor; Ariel Miller
Journal:  J Cell Mol Med       Date:  2011-11       Impact factor: 5.310

9.  Self-assembled monolayers for MALDI-TOF mass spectrometry for immunoassays of human protein antigens.

Authors:  Steven M Patrie; Milan Mrksich
Journal:  Anal Chem       Date:  2007-06-28       Impact factor: 6.986

10.  Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group.

Authors:  Fay Betsou; Alexandre Bulla; Sang Yun Cho; Judith Clements; Rodrigo Chuaqui; Domenico Coppola; Yvonne De Souza; Annemieke De Wilde; William Grizzle; Fiorella Guadagni; Elaine Gunter; Stacey Heil; Verity Hodgkinson; Joseph Kessler; Michael Kiehntopf; Hee Sung Kim; Iren Koppandi; Katheryn Shea; Rajeev Singh; Marc Sobel; Stella Somiari; Demetri Spyropoulos; Mars Stone; Gunnel Tybring; Klara Valyi-Nagy; Gert Van den Eynden; Lalita Wadhwa
Journal:  Biopreserv Biobank       Date:  2016-04-05       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.